跳至主要内容
临床试验/NCT04432532
NCT04432532撤回不适用

Neuroendocrine and Adrenal Tumors: Biochemical, Histopathologic and Genetic Studies

University of Pennsylvania0 个研究点目标入组 999 人开始时间: 2025年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
999
主要终点
Survival

研究概览

简要总结

This is a prospective study of rare neuroendocrine and adrenal tumors. Subjects will be enrolled via informed consent, and blood and/or saliva and tissue will be collected. This is designed to work in conjunction with IRB#831990 which is a retrospective protocol. The University of Pennsylvania will be a contributing site with the University of Michigan as the coordinating site for the A5 alliance, a multi-institutional collaborative designed to study neuroendocrine and adrenal tumors.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosed with neuroendocrine and/or an adrenal tumor

排除标准

  • pregnant women
  • prisoners
  • people under the age of 18

结局指标

主要结局

Survival

时间窗: 10 years

次要结局

  • Tumor Recurrence(10 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Heather Wachtel, MD

Assistant Professor of Surgery

University of Pennsylvania

相似试验